Marksans Pharma Ltd (MARKSANS)

NSE · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

₹306.20

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹306.20 on 30 Oct 2026. The share price traded between ₹155.00 and ₹350.95 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹306.20

Low ₹155.00High ₹350.95

Market cap₹13,892 crorelast close × shares
P/E26.8on reported profit, last four quarters, consolidated
Net profit₹521 crlast 12 months
Return on equity15.2%year to Mar 2026
EBITDA margin20%year to Mar 2026
Debt to equity0.11year to Mar 2026
Net margin14.2%year to Mar 2026
Dividend yield0.30%last 12 months

Price trend

Revenue and profit

RevenueNet profit₹ crore
01,0002,0003,000
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue1,4911,8522,1772,6232,951
Net profit187265315383420
EBITDA margin17%18%21%20%20%
Borrowings111123244322343

₹ crore. Over three years, compounded: revenue grew 16.8% a year, net profit grew 16.6% a year.

Recent filings

Questions about Marksans Pharma Ltd

What is Marksans Pharma Ltd's market value?

Marksans Pharma Ltd's market value is ₹13,892 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 26.8, the last close over earnings per share for the last four reported quarters.

When are Marksans Pharma Ltd's next results?

Marksans Pharma Ltd's next results are listed for 4 Nov 2026 (the exchange's notice: Financial Results). Dates are as the company announced them, on the list of 30 Oct 2026.

Who are Marksans Pharma Ltd's largest named shareholders?

In the shareholding pattern for the quarter ended 30 Sep 2026, the largest named holders above 1% were: MARK SALDANHA (promoter group) 43.8%; ORBIMED ASIA IV MAURITIUS FVCI LIMITED (public) 8.62%; UTI-HEALTHCARE FUND (public) 1.66%. Percentages are of all shares.

Go further with MARKSANS

Free to start: test a trading idea on MARKSANS's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceuticals), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.